Be The First To
Dynavax Technologies is trying to reprogram the way the body reacts to disease. The firm focuses on immunostimulatory sequences (ISS), short strands of DNA found to strengthen the immune system. The company's lead candidate in clinical trials is HEPLISAV, a hepatitis B vaccine. Other candidates in the company's pipeline include a universal flu vaccine that would cover a wider span of flu viruses than traditional flu vaccines, as well as potential treatments for asthma, hepatitis C, and autoimmune and inflammatory diseases. To share the expense and risk of development...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Accepted Offer – Interviewed in Berkeley, CA (US) Dec 2011 – Reviewed Oct 17, 2012
Interview Details I submitted my resume on-line; was contacted by the HR Representative; went in for face to face interviews; met with various department heads; – Full Interview
Please try to be as detailed as possible regarding the technical question, business case, etc. – Answer Question
Let us know if we're missing any workplace or industry recognition –